CCL13 antibody (AA 17-81) (FITC)
Quick Overview for CCL13 antibody (AA 17-81) (FITC) (ABIN7145952)
Target
See all CCL13 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 17-81
-
Cross-Reactivity
- Human
-
Purification
- >95%, Protein G purified
-
Immunogen
- Recombinant Human C-C motif chemokine 13 protein (17-81AA)
-
Isotype
- IgG
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- CCL13 (Chemokine (C-C Motif) Ligand 13 (CCL13))
-
Alternative Name
- CCL13
-
Background
-
Background: Chemotactic factor that attracts monocytes, lymphocytes, basophils and eosinophils, but not neutrophils. Signals through CCR2B and CCR3 receptors. Plays a role in the accumulation of leukocytes at both sides of allergic and non-allergic inflammation. May be involved in the recruitment of monocytes into the arterial wall during the disease process of atherosclerosis. May play a role in the monocyte attraction in tissues chronically exposed to exogenous pathogens.
Aliases: C-C motif chemokine 13 antibody, CCL13 antibody, CCL13_HUMAN antibody, Chemokine (C C motif) ligand 13 antibody, CK beta 10 antibody, CK-beta-10 antibody, CKb10 antibody, MCP-4 antibody, MGC17134 antibody, Monocyte chemoattractant protein 4 antibody, Monocyte chemotactic protein 4 antibody, NCC 1 antibody, NCC-1 antibody, NCC1 antibody, New CC chemokine 1 antibody, SCYA13 antibody, SCYL1 antibody, short chain antibody, Small inducible cytokine A13 precursor antibody, Small inducible cytokine subfamily A (Cys Cys) member 13 antibody, Small-inducible cytokine A13 antibody
-
UniProt
- Q99616
-
Pathways
- Regulation of Systemic Arterial Blood Pressure by Hormones, The Global Phosphorylation Landscape of SARS-CoV-2 Infection
Target
-